Back to Search
DR. BETH E BLUMENSTEIN M.D.
M.D.
Family Medicine Physician
NPI: 1497727150IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
MD24032(OR)
Education
MICHIGAN STATE UNIVERSITY COLLEGE OF HUMAN MEDICINE
Class of 1999
Research & Publications (13)
A clinical development paradigm for cancer vaccines and related biologics.
PMID 17198079·J Immunother·2007
6-review
Lessons from randomized phase III studies with active cancer immunotherapies--outcomes from the 2006 meeting of the Cancer Vaccine Consortium (CVC).
PMID 17916465·Vaccine·2007
6-review
Factors that predict treatment choice and satisfaction with the decision in men with localized prostate cancer.
PMID 17239276·Clin Genitourin Cancer·2006
8-other
Sample size computation for two-sample noninferiority log-rank test.
PMID 16279355·J Biopharm Stat·2005
8-other
Performance enhancement in swimming: the effect of mental training with biofeedback.
PMID 15712502·J Sci Med Sport·2004
3-trial
American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer.
PMID 12963702·J Clin Oncol·2003
6-review
Prognostic model for predicting survival in men with hormone-refractory metastatic prostate cancer.
PMID 12663709·J Clin Oncol·2003
8-other
Trends in clinical trials in surgical oncology: implications for outcomes research.
PMID 12749522·Clin Ther·2003
6-review
Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer.
PMID 11759643·N Engl J Med·2001
3-trial
The percentage of free prostate-specific antigen does not predict extracapsular disease in patients with clinically localized prostate cancer before radical prostatectomy.
PMID 11488733·BJU Int·2001
8-other
Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study.
PMID 10737480·J Urol·2000
3-trial
The prognostic significance of S-phase analysis in stage Ta/T1 bladder cancer. A Southwest Oncology Group Study.
PMID 10765099·Eur Urol·2000
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 51600 HUNTINGTON RD
LA PINE, OR 97739 - Phone
- (541) 536-3435
Quick Facts
- NPI
- 1497727150
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 27
- Publications
- 13
Are you this provider?
Claim Your Profile